Effectiveness and net cost of reminder/recall for adolescent immunizations

Pediatrics
Christina A SuhAllison Kempe

Abstract

To assess the effectiveness of reminder/recall (R/R) for immunizing adolescents in private pediatric practices and to describe the associated costs and revenues. We conducted a randomized controlled trial in 4 private pediatric practices in metropolitan Denver. In each practice, 400 adolescents aged 11 to 18 years who had not received 1 or more targeted vaccinations (tetanus-diphtheria-acellular pertussis, meningococcal conjugate, or first dose of human papillomavirus vaccine for female patients) were randomly selected and randomized to intervention (2 letters and 2 telephone calls) or control (usual care) groups. Primary outcomes were receipt of >1 targeted vaccines and receipt of all targeted vaccines 6 months postintervention. We calculated net additional revenue for each additional adolescent who received at least 1 targeted vaccine and for those who received all targeted vaccines. Eight hundred adolescents were randomized to the intervention and 800 to the control group. Baseline rates of having already received tetanus-diphtheria-acellular pertussis, meningococcal conjugate, and first dose of human papillomavirus vaccine before R/R ranged from 33% to 54%. Postintervention, the intervention group had significantly higher p...Continue Reading

Citations

Dec 19, 2012·BMC Medical Informatics and Decision Making·Jennifer A PereiraUNKNOWN Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Vaccine Coverage Th
Jan 9, 2014·Gynecologic Oncology·Maria E FernandezSally W Vernon
May 9, 2013·Current Opinion in Pediatrics·Tali CapuaJoseph A Bocchini
Jan 11, 2014·Expert Review of Vaccines·Parth D ShahNoel T Brewer
Jun 27, 2014·Expert Review of Vaccines·Annika M Hofstetter, Susan L Rosenthal
Nov 13, 2015·Expert Review of Vaccines·Robert M JacobsonLila J Finney Rutten
Feb 4, 2016·Human Vaccines & Immunotherapeutics·Elizabeth A SmulianShannon Stokley
Feb 19, 2016·Human Vaccines & Immunotherapeutics·Kristin OliverElizabeth Garland
Apr 29, 2014·Academic Pediatrics·Alison W SavilleAllison Kempe
Sep 10, 2013·Academic Pediatrics·Mandy A AllisonAllison Kempe
Jun 4, 2013·Academic Pediatrics·David G BundyMarlene R Miller
Sep 1, 2015·Pediatric Clinics of North America·Svapna S Sabnis, James H Conway
Aug 25, 2015·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Cynthia M RandPeter G Szilagyi
Apr 11, 2013·Human Vaccines & Immunotherapeutics·Patricia JeudinRebecca B Perkins
Apr 13, 2015·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Cynthia M RandPeter G Szilagyi
Apr 13, 2015·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Stephanie A S StarasElizabeth A Shenkman
Apr 13, 2015·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·David S Bar-ShainDavid C Kaelber
Jan 15, 2014·Clinical Therapeutics·Patricia JeudinRebecca B Perkins
Jun 10, 2014·Journal of Public Health Management and Practice : JPHMP·Holly GroomUNKNOWN Community Preventive Services Task Force
Dec 3, 2014·American Journal of Preventive Medicine·Stephanie L MayneAlexander G Fiks
Apr 29, 2014·Journal of Lower Genital Tract Disease·Antonella F LavelanetCharles J Dunton
Jun 17, 2016·Journal of the American Pharmacists Association : JAPhA·Steve G Robison
Sep 25, 2016·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Jai K DasZulfiqar A Bhutta
Nov 12, 2016·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Cynthia M RandPeter G Szilagyi
Jul 30, 2016·Clinical Pediatrics·Annie-Laurie McReePaul L Reiter
Nov 1, 2016·Clinical Pediatrics·Kristina L BondurantJ Mick Tilford
Feb 18, 2017·Patient Education and Counseling·Diane B FrancisTamera Coyne-Beasley
Jan 11, 2018·Annals of Medicine·Aria C AttiaAna E Núñez
Apr 4, 2018·Psychological Science in the Public Interest : a Journal of the American Psychological Society·Noel T BrewerAllison Kempe
Jan 18, 2018·The Cochrane Database of Systematic Reviews·Julie C Jacobson VannPeter G Szilagyi
Apr 2, 2019·Human Vaccines & Immunotherapeutics·Vincenza GianfrediPier Luigi Lopalco
May 17, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sten H VermundCarolyn M Audet
Dec 4, 2019·Current Opinion in Pediatrics·Jessica R CataldiSean T O'Leary
May 20, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Electra D PaskettMira L Katz
Jul 3, 2021·Vaccines·Edison J MavundzaCharles S Wiysonge

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.